| Dr Alae Abod Yaseen, MD | |
|
Msc (pathology) 1 University Of New Mexico, Albuquerque, NM 87131-0001 | |
| (505) 938-8456 | |
| (505) 938-8414 |
| Full Name | Dr Alae Abod Yaseen |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 13 Years |
| Location | Msc (pathology) 1 University Of New Mexico, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902224488 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sutter Medical Center, Sacramento | Sacramento, CA | Hospital |
| Methodist Hospital Of Sacramento | Sacramento, CA | Hospital |
| Sutter Roseville Medical Center | Roseville, CA | Hospital |
| Sutter Auburn Faith Hospital | Auburn, CA | Hospital |
| Sutter Solano Medical Center | Vallejo, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Pathology Medical Group Inc | 2860489218 | 29 |
News Archive
A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.
Researchers at Cedars-Sinai have launched a new clinical trial to investigate the effects of a cancer-fighting drug therapy that has shown favorable outcomes in patients with advanced metastatic prostate cancer.
MedAssurant, a leading provider of data-driven healthcare solutions, today announced the initiation of a joint study with the University of North Carolina to assess the relationship between the use of long-acting insulin to treat diabetes and the development of cancer.
The elimination of extensive routine preoperative tests and consultations represents an area of potentially large health care savings across many disciplines, particularly for low-risk patients being evaluated for cataract surgery. It is also a major theme of the Choosing Wisely campaign from the American Board of Internal Medicine.
› Verified 5 days ago
| Entity Name | Diagnostic Pathology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700961927 PECOS PAC ID: 2860489218 Enrollment ID: O20040427001740 |
News Archive
A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.
Researchers at Cedars-Sinai have launched a new clinical trial to investigate the effects of a cancer-fighting drug therapy that has shown favorable outcomes in patients with advanced metastatic prostate cancer.
MedAssurant, a leading provider of data-driven healthcare solutions, today announced the initiation of a joint study with the University of North Carolina to assess the relationship between the use of long-acting insulin to treat diabetes and the development of cancer.
The elimination of extensive routine preoperative tests and consultations represents an area of potentially large health care savings across many disciplines, particularly for low-risk patients being evaluated for cataract surgery. It is also a major theme of the Choosing Wisely campaign from the American Board of Internal Medicine.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alae Abod Yaseen, MD Msc Pathology Department 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (502) 852-8203 | Dr Alae Abod Yaseen, MD Msc (pathology) 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (505) 938-8456 |
News Archive
A team of researchers, led by Samuel K. Sia, associate professor of biomedical engineering at Columbia Engineering, has developed a low-cost smartphone accessory that can perform a point-of-care test that simultaneously detects three infectious disease markers from a finger prick of blood in just 15 minutes.
Researchers at Cedars-Sinai have launched a new clinical trial to investigate the effects of a cancer-fighting drug therapy that has shown favorable outcomes in patients with advanced metastatic prostate cancer.
MedAssurant, a leading provider of data-driven healthcare solutions, today announced the initiation of a joint study with the University of North Carolina to assess the relationship between the use of long-acting insulin to treat diabetes and the development of cancer.
The elimination of extensive routine preoperative tests and consultations represents an area of potentially large health care savings across many disciplines, particularly for low-risk patients being evaluated for cataract surgery. It is also a major theme of the Choosing Wisely campaign from the American Board of Internal Medicine.
› Verified 5 days ago